Compare WSM & VTRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WSM | VTRS |
|---|---|---|
| Founded | 1956 | 1961 |
| Country | United States | United States |
| Employees | N/A | 30000 |
| Industry | Home Furnishings | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.2B | 21.0B |
| IPO Year | 1995 | 2019 |
| Metric | WSM | VTRS |
|---|---|---|
| Price | $252.90 | $18.09 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 23 | 12 |
| Target Price | ★ $246.35 | $19.70 |
| AVG Volume (30 Days) | 766.1K | ★ 8.5M |
| Earning Date | 11-18-2026 | 11-05-2026 |
| Dividend Yield | 1.17% | ★ 2.60% |
| EPS Growth | ★ 0.57 | N/A |
| EPS | ★ 4.77 | 0.05 |
| Revenue | $7,806,816,000.00 | ★ $14,299,900,000.00 |
| Revenue This Year | $5.95 | $3.44 |
| Revenue Next Year | $5.26 | $1.68 |
| P/E Ratio | ★ $54.64 | $370.63 |
| Revenue Growth | ★ 1.24 | N/A |
| 52 Week Low | $165.51 | $9.92 |
| 52 Week High | $260.94 | $18.75 |
| Indicator | WSM | VTRS |
|---|---|---|
| Relative Strength Index (RSI) | 60.93 | 54.54 |
| Support Level | $216.31 | $15.94 |
| Resistance Level | $254.89 | $18.30 |
| Average True Range (ATR) | 6.68 | 0.47 |
| MACD | 1.42 | 0.03 |
| Stochastic Oscillator | 67.18 | 62.63 |
With a retail and direct-to-consumer presence, Williams-Sonoma is a player in the nearly $300 billion domestic home category and $450 billion international home market, focused on expanding its exposure in the B2B ($80 billion total addressable market), marketplace, and franchise areas. Namesake Williams-Sonoma (153 stores) offers high-end cooking essentials, while Pottery Barn (181) provides casual home accessories. West Elm (117) is an emerging concept for young professionals, and Rejuvenation (13) offers lighting and house parts. Brand extensions include Pottery Barn Kids and Pottery Barn Teen (43) as well as Mark & Graham and GreenRow. Williams-Sonoma also has a business-to-business team that supports projects that range from residential to large-scale commercial.
Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up one-third of Viatris' total sales. The remaining sales are derived from its portfolio of legacy products, including Lipitor, Norvasc, Lyrica, and Viagra.